Search results
Results from the WOW.Com Content Network
Laron syndrome (LS), also known as growth hormone insensitivity or growth hormone receptor deficiency (GHRD), is an autosomal recessive disorder characterized by a lack of insulin-like growth factor 1 (IGF-1; somatomedin-C) production in response to growth hormone (GH; hGH; somatotropin). [6]
Low levels of growth hormone may present with low energy, body aches, or subtle wrinkling of the skin around the eyes or mouth. [6] [8] The symptoms of anti-diuretic hormone deficiency are increased thirst, excessive urination, headache, and fatigue. [13] Hematological changes might be seen as well such as anemia or low platelets ...
Some cases are associated with a lack of other pituitary hormones, in which case it is known as combined pituitary hormone deficiency. [4] Diagnosis involves blood tests to measure growth hormone levels. [2] Treatment is by growth hormone replacement using synthetic human growth hormone. [1] The frequency of the condition is unclear. [2]
For example, a child who has a profound deficiency in growth hormone (especially if they are a cancer survivor with damage to the pituitary gland) may need to continue taking HGH as an adult, ...
Common problems include hypercalcaemia and nephrocalcinosis (due to a lack of calcitonin from the thyroid), and pituitary problems (such as growth hormone deficiency). [4] Antibodies against NLRP5 may lead to hypoparathyroidism. [citation needed]
Menopause, perimenopause and dental symptoms. Menopause happens when a woman goes 12 consecutive months without a menstrual period. But some of the hormone-related dental problems may begin during ...
Several aspects of PWS support the concept of a growth hormone deficiency. Specifically, individuals with PWS are obese with short stature, abnormal body composition, reduced fat-free mass, reduced lean body mass and total energy expenditure, and decreased bone density. PWS is characterized by hypogonadism.
Hypoprolactinemia can result from autoimmune disease, [2] hypopituitarism, [1] growth hormone deficiency, [2] hypothyroidism, [2] excessive dopamine action in the tuberoinfundibular pathway and/or the anterior pituitary, and ingestion of drugs that activate the D 2 receptor, such as direct D 2 receptor agonists like bromocriptine and pergolide, and indirect D 2 receptor activators like ...